Canvas Medical is a technology company.
Canvas Medical has raised $44.0M across 3 funding rounds.
Canvas Medical has raised $44.0M in total across 3 funding rounds.
Canvas Medical is a San Francisco-based technology company that builds a certified, programmable electronic medical record (EMR) platform integrated with revenue cycle management, scheduling, billing, and AI-powered tools to streamline clinical workflows.[1][3][7] It serves care delivery organizations—from specialty startups to risk-bearing medical groups and enterprises—solving the problem of rigid, inefficient EMRs by enabling deep customization, real-time data access via FHIR APIs, and automation that reduces administrative burdens while accelerating patient care.[1][2][4] Recent growth includes the launch of Hyperscribe, an open-source AI copilot for ambient clinical documentation and multi-agent actions, alongside a generally available SDK, positioning Canvas as a leader in AI-driven healthcare automation.[1][4]
Canvas Medical was founded in 2015 by Andrew Hines, a data scientist, after he observed his wife, family nurse practitioner Annalies, struggling with poor medical software that hindered her work.[3][4] Hines, now CTO, partnered with CTO Beau Gunderson to develop a new EMR architecture leveraging accelerated computing for better clinician experiences.[3] Early development involved close collaboration with design partners like Dignity Health Medical Foundation, culminating in the first clinic going live on the Canvas Core Platform after several years of building add-on apps.[3] The company evolved from a core EMR with revenue cycle features to a developer-focused platform in 2021 with a dashboard launch, and Adam Farren became CEO in 2024 after joining as president and COO in 2023.[4]
Canvas stands out in the EMR market through its programmable, cloud-native architecture that combines SaaS ease with enterprise-grade customization:
These features enable "care modeling" for optimized, tailored EMR experiences beyond traditional SaaS limitations.[5][6]
Canvas rides the wave of AI-augmented healthcare and interoperable data standards, capitalizing on FHIR adoption and clinician burnout from legacy EMRs that consume up to 50% of their time on documentation.[1][4][6] Timing is ideal amid regulatory pushes for open APIs (e.g., ONC certification) and the explosion of AI agents in medicine, where Canvas's architecture provides instant patient context and real-time streams that generic LLMs lack.[1][4] Market forces like value-based care, rising specialty startups, and payer-clinician data needs favor its unified platform, which eliminates silos and supports scalable automation.[1][6] By open-sourcing Hyperscribe and SDK tools, Canvas influences the ecosystem, empowering developers and clinics to innovate collaboratively, much like modern cloud platforms disrupted on-premise software.[4][7]
Canvas is poised to dominate extensible EMRs with AI orchestration, with the SDK and Hyperscribe enabling rapid adoption of agentic workflows that execute clinical actions safely.[4] Upcoming trends like multi-agent AI chains, broader FHIR ecosystems, and hybrid SaaS models will amplify its momentum, potentially expanding into enterprise-scale risk-bearing groups and international markets.[1][5] As AI governance demands rise, its transparent, modifiable open-source approach could set industry benchmarks, evolving Canvas from an EMR provider to a foundational platform for "good medicine" automation—building directly on Hines's vision of software that empowers clinicians rather than burdens them.[3][4]
Canvas Medical has raised $44.0M in total across 3 funding rounds.
Canvas Medical's investors include AlleyCorp, DFJ, Helium-3 Ventures, Inspired Capital, M13, Socially Financed, Vera Equity, Steve Salis, 125 Ventures, 14W, Audrey Capital, BBG Ventures.
Canvas Medical has raised $44.0M across 3 funding rounds. Most recently, it raised $24.0M Series B in July 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2022 | $24.0M Series B | AlleyCorp, DFJ, Helium-3 Ventures, Inspired Capital, M13, Socially Financed, Vera Equity, Steve Salis | |
| Apr 1, 2021 | $17.0M Series A | DFJ, Helium-3 Ventures, Inspired Capital, M13, Socially Financed, Vera Equity, Steve Salis | |
| Mar 1, 2018 | $3.0M Seed | 125 Ventures, 14W, Audrey Capital, BBG Ventures, Bond, BoxGroup, Dragoneer Investment Group, Future Perfect Ventures, General Catalyst, GenNx360, GE Ventures, Great Oaks Venture Capital, Hoxton Ventures, Lux Capital, Oak HC/FT, Sequoia Capital, Supply Change Capital, Target Global, Teamworthy Ventures, Anne Wojcicki, Julie McDermott |